MedPath
TGA Approval

SYNACTHEN tetracosactide (tetracosactrin) 0.25mg/1mL injection ampoule (11058)

11058

SYNACTHEN tetracosactide (tetracosactrin) 0.25mg/1mL injection ampoule

Atnahs Pharma Australia Pty Ltd

August 2, 1991

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/8084a9ab3ad7adcf7893cf49868b39ac.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/276330de551c9880bd2d48f0066bae08.pdf

Active Ingredients

tetracosactide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.